These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


371 related items for PubMed ID: 2982949

  • 1. Human natural killer cells limit replication of herpes simplex virus type 1 in vitro.
    Fitzgerald PA, Mendelsohn M, Lopez C.
    J Immunol; 1985 Apr; 134(4):2666-72. PubMed ID: 2982949
    [Abstract] [Full Text] [Related]

  • 2. Positively selected Leu-11a (CD16+) cells require the presence of accessory cells or factors for the lysis of herpes simplex virus-infected fibroblasts but not herpes simplex virus-infected Raji.
    Fitzgerald-Bocarsly P, Feldman M, Curl S, Schnell J, Denny T.
    J Immunol; 1989 Aug 15; 143(4):1318-26. PubMed ID: 2526183
    [Abstract] [Full Text] [Related]

  • 3. Enhanced lysis of herpes simplex virus type 1-infected mouse cell lines by NC and NK effectors.
    Colmenares C, Lopez C.
    J Immunol; 1986 May 01; 136(9):3473-80. PubMed ID: 2420891
    [Abstract] [Full Text] [Related]

  • 4. Human natural killer cell recognition of herpes simplex virus type 1 glycoproteins: specificity analysis with the use of monoclonal antibodies and antigenic variants.
    Bishop GA, Marlin SD, Schwartz SA, Glorioso JC.
    J Immunol; 1984 Oct 01; 133(4):2206-14. PubMed ID: 6206157
    [Abstract] [Full Text] [Related]

  • 5. Heteroconjugate antibodies enhance cell-mediated anti-herpes simplex virus immunity.
    Paya CV, McKean DJ, Segal DM, Schoon RA, Showalter SD, Leibson PJ.
    J Immunol; 1989 Jan 15; 142(2):666-71. PubMed ID: 2536060
    [Abstract] [Full Text] [Related]

  • 6. Role of interferon in natural kill of HSV-1-infected fibroblasts.
    Fitzgerald PA, von Wussow P, Lopez C.
    J Immunol; 1982 Aug 15; 129(2):819-23. PubMed ID: 6177785
    [Abstract] [Full Text] [Related]

  • 7. Role of interferon in human natural killer activity against target cells infected with HSV-1.
    Bishop GA, Glorioso JC, Schwartz SA.
    J Immunol; 1983 Oct 15; 131(4):1849-53. PubMed ID: 6194217
    [Abstract] [Full Text] [Related]

  • 8. Alternative mechanisms of natural killer cell activation during herpes simplex virus infection.
    Paya CV, Schoon RA, Leibson PJ.
    J Immunol; 1990 Jun 01; 144(11):4370-5. PubMed ID: 2160501
    [Abstract] [Full Text] [Related]

  • 9. Human newborn natural killer cell responses to activation by monoclonal antibodies. Effect of culture with herpes simplex virus.
    Hayward A, Laszlo M, Vafai A.
    J Immunol; 1989 Feb 15; 142(4):1139-43. PubMed ID: 2536766
    [Abstract] [Full Text] [Related]

  • 10. Enhancement of susceptibility of HSV-1-infected cells to natural killer lysis by interferon.
    Muñoz A, Carrasco L, Fresno M.
    J Immunol; 1983 Aug 15; 131(2):783-7. PubMed ID: 6190939
    [Abstract] [Full Text] [Related]

  • 11. Virus-induced enhancement of lymphocyte-mediated antibody-dependent cytotoxicity (ADCC) in vitro.
    Alsheikhly AR, Wåhlin B, Andersson T, Perlmann P.
    J Immunol; 1984 Jun 15; 132(6):2760-6. PubMed ID: 6373918
    [Abstract] [Full Text] [Related]

  • 12. The role of natural killer cells and interferon in resistance to acute infection of mice with herpes simplex virus type 1.
    Bukowski JF, Welsh RM.
    J Immunol; 1986 May 01; 136(9):3481-5. PubMed ID: 2420892
    [Abstract] [Full Text] [Related]

  • 13. Heterogeneity of human NK cells: comparison of effectors that lyse HSV-1-infected fibroblasts and K562 erythroleukemia targets.
    Fitzgerald PA, Evans R, Kirkpatrick D, Lopez C.
    J Immunol; 1983 Apr 01; 130(4):1663-7. PubMed ID: 6601135
    [Abstract] [Full Text] [Related]

  • 14. Interleukin 2 induced non MHC-restricted killing of herpes simplex type-1 (HSV-1) infected allogeneic and autologous lymphoblasts.
    Klimpel GR, Asuncion M, Fons M, Norton JD, Albrecht T, Klimpel KD, Stein MD.
    J Clin Lab Immunol; 1989 May 01; 29(1):1-7. PubMed ID: 2560794
    [Abstract] [Full Text] [Related]

  • 15. Lysis of human cytomegalovirus infected fibroblasts by natural killer cells: demonstration of an interferon-independent component requiring expression of early viral proteins and characterization of effector cells.
    Borysiewicz LK, Rodgers B, Morris S, Graham S, Sissons JG.
    J Immunol; 1985 Apr 01; 134(4):2695-701. PubMed ID: 2579152
    [Abstract] [Full Text] [Related]

  • 16. Replication of herpes simplex virus in human T lymphocytes: characterization of the viral target cell.
    Braun RW, Teute HK, Kirchner H, Munk K.
    J Immunol; 1984 Feb 01; 132(2):914-9. PubMed ID: 6317753
    [Abstract] [Full Text] [Related]

  • 17. Effects of herpes simplex virus on induced cell-mediated cytotoxicity in neonates and adults.
    Chin TW, Plaeger-Marshall S, Ank BJ, Pressman SR, Stiehm ER.
    Nat Immun Cell Growth Regul; 1991 Feb 01; 10(5):237-46. PubMed ID: 1661847
    [Abstract] [Full Text] [Related]

  • 18. Cytolytic activity of natural killer cells and lymphokine activated killer cells against hepatitis A virus infected fibroblasts.
    Baba M, Hasegawa H, Nakayabu M, Fukai K, Suzuki S.
    J Clin Lab Immunol; 1993 Feb 01; 40(2):47-60. PubMed ID: 7932628
    [Abstract] [Full Text] [Related]

  • 19. Impaired in vitro interferon, blastogenic, and natural killer cell responses to viral stimulation in acquired immune deficiency syndrome.
    Hersh EM, Gutterman JU, Spector S, Friedman H, Greenberg SB, Reuben JM, LaPushin R, Matza M, Mansell PW.
    Cancer Res; 1985 Jan 01; 45(1):406-10. PubMed ID: 2578099
    [Abstract] [Full Text] [Related]

  • 20. Natural killer cells lyse autologous herpes simplex virus infected targets using cytolytic mechanisms distributed clonotypically.
    Pietra G, Semino C, Cagnoni F, Boni L, Cangemi G, Frumento G, Melioli G.
    J Med Virol; 2000 Nov 01; 62(3):354-63. PubMed ID: 11055246
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 19.